RT Journal Article
SR Electronic
T1 All Patients with Uncontrolled Blood Pressure on Valsartan Monotherapy Benefit from Switch to Combination Therapy
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 5
SP 9
OP 9
DO 10.1177/155989771005006
UL http://mdc.sagepub.com/content/10/5/9.1.abstract
AB Classifying patients with uncontrolled hypertension by degree of response to valsartan monotherapy has a limited value in predicting which patients will benefit from the addition of hydrochlorothiazide (HCTZ), according to findings from a new study. Despite failing to meet blood pressure (BP) targets with valsartan monotherapy, all patients with stage 2 hypertension experienced dose-dependent improvements in BP control with the addition of HCTZ.